Skip to main content

FDA recall, , High risk

American Regent Nitroglycerin, Cyanocobalamin, Aminocaproic Acid, Atropine Sulfate, Acetylcysteine, Selenious Acid, Multrys, Papaverine HCl, Tralement and Nicardipine Injections

American Regent injections contain particulate matter.

What happened

American Regent, Inc., of Shirley, New York, is conducting a nationwide voluntary recall of multiple injectable products due to the presence of particulate matter identified as hair, glass and/or paraformaldehyde.

The affected products include Tralement, Cyanocobalamin injection USP, Multrys, Aminaocaproic Acid Injection, Selenious Acid Injection, Acetylcysteine Solution, Atropine Sulfate injection, niCARdipine Hydrochloride Injection, Nitroglycerin injection, and Papaverine HCl Injection. The recall began on July 24, 2026, and was added to the FDA's Enforcement Report on August 17, 2026.

2 photos

What to do

If a code on your package is listed below:

  1. Distributors/retailers/healthcare facilities that have the product which is being recalled should stop using and return to place of purchase or discard the product.
  2. Consumers and healthcare professionals with questions regarding this recall can contact American Regent Inc. using the below information.
  3. Patients that use this product which is being recalled should stop using them and contact their doctor or health care provider.
  4. Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

Is yours affected?

12 products

Match the list below, then check the codes the FDA notice also names.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Selenious Acid Injection, USP

    Strength
    12 mcg
    NDC
    • 0517-6502-01
    • 0517-6502-10
    Lot code
    • 25090
  2. Papaverine Hydrochloride Injection, USP 60 mg/2 mL Single dose vial

    NDC
    • 0517-4002-25
    Lot code
    • 25202
    Best-by or expiration date
    11/30/2026 Distribution Dates: 9/30/2025
  3. Tralement (trace elements injection 4*, USP)

    NDC
    • 0517-9305-01
    • 0517-9305-25
    Lot code
    • 25149
    • 25371
  4. Cyanocobalamin injection USP, 1

    Strength
    000 mcg/mL
    NDC
    • 0517-0031-01
    • 0517-0031-25
    Lot code
    • 24297
  5. Multrys (Trace Elements Injection 4, USP), For intravenous infusion

    NDC
    • 0517-9302-01
    • 0517-9302-25
    Lot code
    • 25163
  6. Aminaocaproic Acid Injection, USP

    Strength
    250 mg/mL
    NDC
    • 0517-9120-01
    • 0517-9120-25
    Lot code
    • 24299
  7. Cyanocobalamin injection USP, 10

    Strength
    000 mcg
    NDC
    • 0517-0032-01
    • 0517-0032-25
    Lot code
    • 25082
  8. Acetylcysteine Solution, USP, 20% (

    Strength
    200 mg/mL
    NDC
    • 0517-7604-01
    • 0517-7604-25
    Lot code
    • 24426
  9. Acetylcysteine Solution, USP, 10% (

    Strength
    100 mg/mL
    NDC
    • 0517-7504-01
    • 0517-7504-25
    Lot code
    • 24418
  10. Atropine Sulfate injection, USP

    Strength
    1 mg/mL
    NDC
    • 0517-1001-01
    • 0517-1001-25
    Lot code
    • 24353
  11. niCARdipine Hydrochloride Injection, USP

    Strength
    25 mg
    NDC
    • 72572-470-01
    • 72572-470-10
    Lot code
    • 25295N0C0
  12. Nitroglycerin injection, USP

    Strength
    50 mg
    NDC
    • 0517-4810-01
    • 0517-4810-25
    Lot code
    • 24291

From the FDA notice

Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials (NDC 0517-4810-01), b) 25x10mL vials (NDC 0517-4810-25) RX only, AMERICAN REGENT, INC., Shirley, NY 11967.

Recall details

Company began the recall
Sold in

Nationwide within the U.S

Company
American Regent, Inc.Shirley, New York
Risk

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
99503
Recall numbers
D-0791-2026 to D-0802-2026

All recalls from American Regent, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall · Announced by the company

  2. Listed on Recall Canary

  3. Added to FDA's Enforcement Report

  4. Classified by FDA · In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 10, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)